CUTANEOUS NEUROFIBROMA
Clinical trials for CUTANEOUS NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS NEUROFIBROMA trials appear
Sign up with your email to follow new studies for CUTANEOUS NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cold sore virus shrink NF1 skin tumors?
Disease control Recruiting nowThis early study tests whether a drug called IMLYGIC, made from a modified herpes virus, can be safely injected into painful or disfiguring skin tumors in adults with NF1. Ten participants will receive up to 8 injections over 4 months. The goal is to see if the treatment is toler…
Matched conditions: CUTANEOUS NEUROFIBROMA
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug shows promise for NF1 skin tumors in early trial
Disease control Recruiting nowThis study tests a drug called mirdametinib in adults with neurofibromatosis type 1 (NF1) who have skin tumors called cutaneous neurofibromas. The goal is to find a safe dose and see if the drug can shrink these tumors. About 24 people will take the drug daily or on a three-week-…
Matched conditions: CUTANEOUS NEUROFIBROMA
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC